Latest / Cork News Today | 2 Min News | The Daily News Now!
Pluvicto Access Battle in Ireland | Cork News
A groundbreaking prostate cancer treatment called Pluvicto, approved in Europe since 2022, is sparking a major debate in Ireland. While hailed by doctors as a life-extending breakthrough for advanced prostate cancer patients, Ireland’s health service, HSE, is considering denying public funding — a decision Novartis is challenging. Nearly 30 Irish oncologists have urged the HSE to act, emphasizing the drug’s proven benefits and its use in private care and other EU nations. The HSE insists on careful evaluation to ensure taxpayer value, but the medical community is pushing for access, warning…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.